About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Children With Diabetes at Risk for Heart Disease. | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT02275091

Children With Diabetes at Risk for Heart Disease.

Patients with type 1 diabetes type 1 (DM1) have increased risk of death due to heart disease and stroke. These cardiovascular conditions (CVD) are the leading cause of death in patients with DM1 young...

Lead sponsor: Georgetown University•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Evgenia Gourgari, MD

CONTACT

Kathryn Turner

CONTACT

Sponsors

Lead Sponsor

Georgetown University

Collaborators

Howard University

Patients with type 1 diabetes and healthy controls will have evaluation of their lipid profile. Arterial stiffness, heart rate variability and adiposity measurements will be done in patients with type 1 diabetes and healthy controls. Blood pressure and heart rate will be recorded. 50 ml of urine will be collected from patients and controls. All studies will be performed as a single outpatient visit at Georgetown University.

Age

12 - 21 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Diabetes type 1 or Healthy

Exclusion Criteria

•Taking medications that lower cholesterol Duration of type 1 diabetes \< 1 year.

Related studies

RECRUITINGPhase 3

A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

NCT07222137 · Diabetes Mellitus, Type 1

General Use-results Surveillance With Awiqli in Patients With Diabetes Mellitus

NCT06807190 · Diabetes Mellitus, Type 1

A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugar

NCT07160816 · Diabetes Mellitus, Type 1

RECRUITINGPhase 3

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

NCT04786262 · Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness, and more

Menstrual Cycle Mapping While Using Closed-Loop Insulin Delivery

NCT07478211 · Diabetes Mellitus, Type 1, Energy Metabolism

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 5, 2019Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment240

Start dateOct 2014

Last updatedApr 5, 2019

Condition

Diabetes Mellitus, Type 1 Diabetes Complications

Locations shown

Georgetown-Howard Universities Center

Washington D.C., District of Columbia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 5, 2019Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions